Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
[1] The Medicines and Healthcare products Regulatory Agency (MHRA) has approved its use in the UK, and it must be prescribed by a qualified healthcare professional as part of a comprehensive treatment plan that includes dietary modifications and increased physical activity
This blend exists only for research use
Research suggests it supports liver detoxification processes by helping the organ process and eliminate toxins more efficiently
The FDA has approved specific formulations for different indications: semaglutide 2.4 mg (Wegovy), liraglutide 3 mg (Saxenda), and tirzepatide (Zepbound) are approved for chronic weight management, while all are approved for diabetes at different doses
US$ 22.29
US$ 27.74
US$ 20.20
US$ 20.11
